fda and tirzepatide compounding Allows Compounded During Shortage Review Judge says compounding pharmacies must

Warnings: Thyroid Tumors: Contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M

Because liraglutide and semaglutide have different half-lives and potencies, your provider will likely recommend a short waiting period or a specific tapering schedule to ensure the transition is safe

That is the real reason providers need to know about it when you start GLP-1 therapy

In summary: Sermorelin stimulates natural GH release (acting upstream), while hGH therapy provides external GH (acting downstream)

J Saudi Heart Assoc